Biodegradable ocular implants with long-term release characteristics

Details for Australian Patent Application No. 2005244195 (hide)

Owner Allergan, Inc.

Inventors Shiah, Jane Guo; Lin, Qing; Nivaggioli, Thierry

Agent Davies Collison Cave

Pub. Number AU-B-2005244195

PCT Pub. Number WO2005/110362

Priority 10/837,355 30.04.04 US

Filing date 14 April 2005

Wipo publication date 24 November 2005

Acceptance publication date 30 June 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110362 Priority application(s): WO2005/110362

30 June 2011 Application Accepted

  Published as AU-B-2005244195

27 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244199-Rising stimulation modification

2005244191-Method and apparatus for treating pelvic organ prolapse